Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Allyson M, Pishko"'
Autor:
Sean Hennessy, Rebecca A Hubbard, Vincent Lo Re, Dena M Carbonari, Claudia A Steiner, Yunping Zhou, Cheryl N McMahill-Walraven, Pamala A Pawloski, Laura Hou, Sarah K Dutcher, John G Connolly, Silvia Perez-Vilar, Terese A DeFor, Djeneba Audrey Djibo, Laura B Harrington, Maria E Kempner, Jennifer L Kuntz, Jolene Mosley, Andrew B Petrone, Allyson M Pishko, Meighan Rogers Driscoll, Noelle M Cocoros
Publikováno v:
BMJ Medicine, Vol 2, Iss 1 (2023)
Objective To measure the 90 day risk of arterial thromboembolism and venous thromboembolism among patients diagnosed with covid-19 in the ambulatory (ie, outpatient, emergency department, or institutional) setting during periods before and during cov
Externí odkaz:
https://doaj.org/article/2491d0112e4f451494c117e8637225d9
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 4, Pp n/a-n/a (2022)
Abstract Background The optimal prophylactic preprocedural management of patients with coagulopathy due to liver disease is not known. Objectives Our objective was to compare the efficacy and safety of fresh frozen plasma (FFP) with prothrombin compl
Externí odkaz:
https://doaj.org/article/fa61565c63274e9e823ba2c8ff3b9186
Autor:
Allyson M, Pishko, Ariela L, Marshall
Publikováno v:
Hematology Am Soc Hematol Educ Program
Hematologists are often consulted for thrombocytopenia in pregnancy, especially when there is a concern for a non-pregnancy-specific etiology or an insufficient platelet count for the hemostatic challenges of delivery. The severity of thrombocytopeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b03c48ce346bd7628d14827bbe399411
https://doi.org/10.1182/hematology.2022000375
https://doi.org/10.1182/hematology.2022000375
Publikováno v:
Journal of Obstetrics and Gynaecology Canada.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::850d319e140b43530fe774a7870f4156
https://doi.org/10.1016/j.jogc.2023.05.015
https://doi.org/10.1016/j.jogc.2023.05.015
Autor:
Allyson M Pishko, Bhavya S Doshi
Publikováno v:
Journal of Blood Medicine. 13:255-265
In acquired hemophilia A (AHA), autoantibodies to coagulation factor VIII (FVIII) neutralize FVIII activity leading to a potentially severe bleeding diathesis that carries a high rate of morbidity and mortality. This disorder is rare and occurs mainl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d0938f21c6e5fa0892c3ae82a6ea37a
https://doi.org/10.2147/jbm.s284804
https://doi.org/10.2147/jbm.s284804
Autor:
Allyson M, Pishko, Adam, Cuker
Publikováno v:
Hematology Am Soc Hematol Educ Program
Clinicians generally counsel patients with a history of heparin-induced thrombocytopenia (HIT) to avoid heparin products lifelong. Although there are now many alternative (nonheparin) anticoagulants available, heparin avoidance remains challenging fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be04dbeba2de3839c8f6300e099ddf51
https://doi.org/10.1182/hematology.2021000289
https://doi.org/10.1182/hematology.2021000289
Autor:
Adam Cuker, Allyson M. Pishko
Publikováno v:
International Journal of Laboratory Hematology. 43:96-102
Heparin-induced thrombocytopenia (HIT) is a prothrombotic condition resulting from pathogenic antibodies to complexes of heparin and platelet factor 4 (PF4). The diagnosis of HIT can be challenging due to the widespread use of heparin and the frequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f34cac05d9b10e212bd19f8f8f6e9ea
https://doi.org/10.1111/ijlh.13564
https://doi.org/10.1111/ijlh.13564
Autor:
Andrew Matthews, Jay Giri, Adam Cuker, Ann Tierney, Pardis Niami, Elizabeth A. Traxler, Nathalie van der Rijst, Tara Cooper, Ella Ishaaya, Srinath Adusumalli, Steven C. Pugliese, Jennifer Yui, Todd E.H. Hecht, Allyson M. Pishko, Christopher Domenico, Rim Halaby, Jacob T. Gutsche
Publikováno v:
Journal of Thrombosis and Haemostasis
Background Studies report hypercoagulability in coronavirus disease 2019 (COVID‐19), leading many institutions to escalate anticoagulation intensity for thrombosis prophylaxis. Objective To determine the bleeding risk with various intensities of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af6c1e0ab4c74dfc120a84318d36864
https://doi.org/10.1111/jth.15310
https://doi.org/10.1111/jth.15310
Publikováno v:
Blood advances.
Immune thrombotic thrombocytopenic purpura (iTTP) is an acquired, fatal microangiopathy if untreated. Randomized controlled trials (RCTs) demonstrated faster time to response with addition of caplacizumab to standard of care (SOC). However, concerns
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16e3109823c95e53f4ea5693a96dd255
https://pubmed.ncbi.nlm.nih.gov/36053773
https://pubmed.ncbi.nlm.nih.gov/36053773
Publikováno v:
Blood. 140:13134-13135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a876f7d485ea2596ee6ac48ef347c79f
https://doi.org/10.1182/blood-2022-159795
https://doi.org/10.1182/blood-2022-159795